Therapeutic MK2 inhibition blocks pathological vascular smooth muscle cell phenotype switchJ.W. Tierney(Vanderbilt University), Craig L. Duvall(Vanderbilt University)JCI InsightOctober 7, 202110.1172/jci.insight.142339Cited by 26SaveCiteExport RISWatch citationsRelated PapersCore polymer optimization of ternary siRNA nanoparticles enhances in vivo safety, pharmacokinetics, and tumor gene silencing|Biomaterials|2023|22